Skip to main content
. 2012 Nov 16;15(5):542–547. doi: 10.1093/neuonc/nos284

Fig. 1.

Fig. 1.

Kaplan–Meier curves in all glioma population show significant overall survival difference between tumor class 1-IDH mut/1p-19q codel/EGFR normal-(median OS 211.2 months), tumor class-2 IDH mut/1p-19q normal/EGFR normal-(median OS 103.9 months), tumor class 3-IDH wt/1p-19q normal/EGFR normal-(median OS 26.5 months), and tumor class 4-IDH wt/1p-19q normal/EGFR amplification-(median OS 16.6 months).